Small-Molecule Ferroptotic Agents with Potential to Selectively Target Cancer Stem CellsWilliam R. Taylor, L. M. Viranga Tillekeratne|Scientific Reports|2019Cited by 68
Rational design of metabolically stable HDAC inhibitors: An overhaul of trifluoromethyl ketonesRiddhidev Banerjee, L. M. Viranga Tillekeratne|European Journal of Medicinal Chemistry|2022Cited by 15